UCSF

ZINC03952881

Substance Information

In ZINC since Heavy atoms Benign functionality
October 24th, 2005 26 No

Other Names:

(3Z)-3-[[4-(2-carboxyethylcarbamoyl)phenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylic acid

(E)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid

(E)-5-((4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid; (E)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid; 3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid; 5-[4-(2

(E)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid; Balsalazida [Spanish]; Balsalazide; Balsalazide [INN:BAN]; Balsalazido [Spanish]; Balsalazidum [Latin]; Benzoic acid, 5-((4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydrox

(E)-5-((4-((2-Carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acid

(E)-5-((4-((2-Carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoicacid

(E)-5-((p-((2-Carboxyethyl)carbamoyl)phenyl)azo)salicylic acid, disodium salt, dihydrate; BALSALAZIDE DISODIUM; BSZ; BX661A; Balsalazide disodium [USAN]; Balsalazide disodium hydrate; Benzoic Acid,5-((1E)-(4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-

(E)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid

(E)-5-[[4-[[(2-Carboxyethyl)amino]-carbonyl]phenyl]azo-2-hydroxybenzoic acid

sal-

3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid

5-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}diazen-1-yl)-2-hydroxybenzoic acid

5-[(E)-{4-[(2-carboxyethyl)carbamoyl]phenyl}diazenyl]-2-hydroxybenzoic acid

5-[4-(2-carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid

80573-04-2

80573-04-2; Balsalazide (INN); D07488

AC1O3RJF

Ambap80573-04-2

Balsalazida

Balsalazida [Spanish]

Balsalazida [Spanish];Balsalazide disodium;Balsalazido [Spanish];Balsalazidum [Latin]

balsalazida; balsalazide; balsalazidum

Balsalazide

Balsalazide (BAN

Balsalazide (INN)

Balsalazide Disodium

Balsalazide disodium dihydrate

Balsalazide disodium salt dihydrate

Balsalazide Sodium

balsalazide sodium; bisalazide sodique; bisalazine disodium; disodium 5-((4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoate dihydrate; disodium 5-[4-(2-carboxyethylcarbamoyl)phenylazo]salicylate; disodium balsalazide; natrii balsalazidum; s

Balsalazide [INN:BAN]

Balsalazide, 98.5%+

BALSALAZIDE; CPD000469221; SAM001246804

Balsalazidedisodium

Balsalazido

Balsalazido [Spanish]

Balsalazidum

Balsalazidum [Latin]

Balzide

Benzoic acid, 5-((4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxy-, (E)-

BIDD:GT0772

BX-661A

C17H15N3O6

Carbadox

CHEBI:267413

CID6335412

Colazal

Colazide

CPD000469221

CPD000469221; BALSALAZIDE

D07488

DAP000733

DB01014

Giazo

HMS2052K19

INN); Balsalazide Disodium (FDA

LS-190102

LS-36369

MFCD00868204

MFCD01631117

MFCD07802815

MLS001424257

QA-3698

SAM001246804

SMR000469221

UNII-P80AL8J7ZP

USAN)

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 2.75 5.25 -98.72 2 9 -2 154 355.306 7

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 2.80e-02 g/l DrugBank-approved
ALOGPS_SOLUBILITY 6.21e-02 g/l DrugBank-approved
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Therapy antiinflammatory SMDC Pharmakon
PUBCHEM_PATENT_ID EP0554291A1; EP0929578A1; EP0974344A2; EP0974344A3; EP1003501A1; EP1054998A1; US5498608; US5795909; US5905073; US6040147; WO1996030016A2; WO1997029131A1; WO1997044063A2; WO1998041212A1; WO1998043630A1; WO1998050043A1; WO1999001089A1; WO1999015629A1; WO199 IBM Patent Data
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP00900b NIH Clinical Collection via PubChem
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP00900b NIH Clinical Collection via PubChem
Purity USP24 APIChem

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )